Megan Charko - National Research Senior Marketing
| NRC Stock | USD 34.87 0.10 0.29% |
Executive
Megan Charko is Senior Marketing of National Research Corp
| Address | 1245 Q Street, Lincoln, NE, United States, 68508 |
| Phone | 402 475 2525 |
| Web | https://www.nrchealth.com |
National Research Management Efficiency
The company has Return on Asset of 0.1981 % which means that on every $100 spent on assets, it made $0.1981 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.512 %, implying that it generated $0.512 on every 100 dollars invested. National Research's management efficiency ratios could be used to measure how well National Research manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.55, whereas Return On Capital Employed is forecasted to decline to 0.28. At present, National Research's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.55, whereas Total Assets are forecasted to decline to about 80.7 M.Similar Executives
| Found 13 records | EXECUTIVE Age | ||
| Thomas Bartrum | Privia Health Group | 56 | |
| Shawn OConnor | Simulations Plus | 64 | |
| Sarath Degala | Privia Health Group | N/A | |
| Eric Beyer | Privia Health Group | N/A | |
| Scott Siler | Simulations Plus | N/A | |
| Chris Voigt | Privia Health Group | N/A | |
| John MS | Simulations Plus | 44 | |
| Jenny Harding | Privia Health Group | N/A | |
| Lindsay Luke | Simulations Plus | N/A | |
| Robert Borchert | Privia Health Group | N/A | |
| Arlene Padron | Simulations Plus | N/A | |
| Dana CPA | Privia Health Group | N/A | |
| Jay Stevens | Privia Health Group | N/A | |
Management Performance
National Research Corp Leadership Team
Elected by the shareholders, the National Research's board of directors comprises two types of representatives: National Research inside directors who are chosen from within the company, and outside directors, selected externally and held independent of National. The board's role is to monitor National Research's management team and ensure that shareholders' interests are well served. National Research's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, National Research's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, CFO, Fin | ||
| Helen Hrdy, Chief Officer | ||
| Gregory MS, Chief Officer | ||
| Linda Stacy, Principal Officer | ||
| Megan Charko, Senior Marketing | ||
| Andy Monnich, Chief Officer | ||
| Jona Raasch, Chief Officer | ||
| Kevin CPA, CFO, Finance | ||
| Jon Boumstein, Chief Officer | ||
| Jason Hahn, Chief Officer | ||
| Michael Hays, CEO, Director | ||
| Christophe Louvion, Chief Officer |
National Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is National Research a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.51 | ||||
| Return On Asset | 0.2 | ||||
| Profit Margin | 0.21 % | ||||
| Operating Margin | 0.31 % | ||||
| Current Valuation | 863.9 M | ||||
| Shares Outstanding | 23.85 M | ||||
| Shares Owned By Insiders | 36.76 % | ||||
| Shares Owned By Institutions | 51.01 % | ||||
| Number Of Shares Shorted | 205.15 K | ||||
| Price To Earning | 26.72 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards National Research in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, National Research's short interest history, or implied volatility extrapolated from National Research options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for National Stock analysis
When running National Research's price analysis, check to measure National Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Research is operating at the current time. Most of National Research's value examination focuses on studying past and present price action to predict the probability of National Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Research's price. Additionally, you may evaluate how the addition of National Research to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is National Research's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.339 | Dividend Share 0.48 | Earnings Share 1.25 | Revenue Per Share 6.055 | Quarterly Revenue Growth (0) |
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.